Nuveen Asset Management, LLC Brainstorm Cell Therapeutics Inc. Transaction History

Nuveen Asset Management, LLC

  • $345 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$3.01 - $4.01 $365,338 - $486,713
-121,375 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$3.46 - $7.88 $7,781 - $17,722
-2,249 Reduced 1.82%
121,375 $464,000
Q4 2020

Feb 16, 2021
BUY
$3.99 - $17.73 $67,989 - $302,119
17,040 Added 15.99%
123,624 $1.48 Million
Q3 2020

Nov 16, 2020
BUY
$11.19 - $16.92 $10,317 - $15,600
922 Added 0.87%
106,584 $1.8 Million
Q2 2020

Aug 14, 2020
BUY
$4.42 - $12.66 $467,026 - $1.34 Million
105,662 New
105,662 $1.19 Million

Others Institutions Holding BCLI

# of Institutions
33
Shares Held
10.5M
Call Options Held
160K
Put Options Held
30.5K
View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

BCLI Quotes by TradingView
  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $69.3M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email